Is Canopy Growth (TSX:WEED) Stock a Buy After New CEO Appointment?

Marijuana leader Canopy Growth (TSX:WEED)(NYSE:CGC) stock rallied over 11% on Monday after the company finally announced new CEO David Klein as the preferred replacement for ousted co-founder Bruce Linton and the stepping down of interim leader and co-founder Mark Zekulin later this month. The new CEO will assume the reins on January 14 of 2020. Canopy has clearly decided to…

Read More

KALY – Kali-Extracts Confirms Scheduled Update on Capital Infusion Plan at $50 Million Valuation

Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today confirmed plans to publish an update tomorrow on Tuesday, December 10, 2019 to present capital infusion plans for the company's cannabis extract biopharmaceutical business valued at $50 million. ALYI is proceeding with a capital infusion plan to accelerate the growth of its cannabis biopharmaceutical technology. KALY has recently announced receiving…

Read More

This Cannabis Stock Is Building Something Truly Special

The cannabis opportunity is unlike any other. Multi-billion-dollar markets rarely appear virtually overnight. Both novice and veteran investors alike have the chance to get rich. Just don’t assume that every cannabis stock will put you on the road to riches. Think back to the dot-com bubble of the 1990s. There were literally hundreds of internet stocks to invest in. Two…

Read More

Will HEXO (TSX:HEXO) Kill Canopy Growth (TSX:WEED) Stock?

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) was once cannabis royalty. In just three years, the stock rose from $0.50 to $10. The recent marijuana pullback has hampered expectations, but HEXO’s management team continues to invest in its long-term strategy. If successful, HEXO’s differentiated approach could spell trouble for other pot stocks, namely Canopy Growth Corp. (TSX:WEED)(NYSE:CGC). That’s because HEXO is creating a scalable…

Read More

KALY – Kali-Extracts Proceeds With Capital Infusion Plan At $50 Million Valuation

Kali Extracts

Dallas, Texas–(Newsfile Corp. – December 6, 2019) – Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) (“KALY”) today announced it will proceed with a capital infusion plan to accelerate the growth of its cannabis biopharmaceutical technology. KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis biopharmaceutical technology valuing the technology at $50 million. KALY…

Read More

Canadian Investors: 3 Top TSX Stocks for December

The Canadian stock market has hosted some truly incredible stocks in recent decades. Some have returned more than 10,000%, while others have increased their dividends for 30 years straight. Whether you prefer growth, income, or both, the TSX has a stock for you. This fall, several notable TSX stocks have gone on sale. This month could be your last chance…

Read More

Cannabis Beginners: 2 Pot Stocks for New Investors

Pot stocks were the best way to get rich in 2018. Nearly every cannabis company saw their share price increase by leaps and bounds. Doubling and tripling in value were commonplace. This year, the tables were turned. Many marijuana stocks have lost more than 50% in value. But don’t be scared: if you’ve been waiting to invest in cannabis, there…

Read More

PURA and KALY Announce Landing First Kenyan Coffee Shipment Adding to $8 Million 2020 Beverage Revenue Target

Puration, Inc.

Dallas, Texas–(Newsfile Corp. – December 3, 2019) – Puration, Inc. (OTC Pink: PURA) today announced the company has landed its first Kenyan coffee shipment. The company recently announced it will begin producing CBD infused Fair Trade coffee from Kenya. Now that the first shipment from Kenya has arrived, the company can begin formulating the CBD infusion. PURA has engaged Kali-Extracts,…

Read More